123 related articles for article (PubMed ID: 33853757)
1. A comprehensive assessment of the impact of a colorectal cancer screening program in a northern Italian area.
Pancheri S; Pertile R; Armelao F; Rizzello RV; Piffer S; Zorzi M; Guzzinati S; Ferro A; Mantovani W; de Pretis G
Dig Liver Dis; 2022 Mar; 54(3):400-406. PubMed ID: 33853757
[TBL] [Abstract][Full Text] [Related]
2. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
3. Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
Ibáñez-Sanz G; Milà N; Vidal C; Rocamora J; Moreno V; Sanz-Pamplona R; Garcia M;
PLoS One; 2021; 16(6):e0253369. PubMed ID: 34191813
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with symptom- and screening-detected colorectal cancer.
Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
[TBL] [Abstract][Full Text] [Related]
7. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
[TBL] [Abstract][Full Text] [Related]
8. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
[TBL] [Abstract][Full Text] [Related]
9. Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.
Parente F; Vailati C; Boemo C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Cereda D; Cremaschini M; Moretti R
Dig Liver Dis; 2015 Jan; 47(1):68-72. PubMed ID: 25306524
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
11. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
Zorzi M; Zappa M;
Gut; 2020 Feb; 69(2):311-316. PubMed ID: 31040168
[TBL] [Abstract][Full Text] [Related]
12. Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.
Idigoras Rubio I; Arana-Arri E; Portillo Villares I; Bilbao Iturribarrria I; Martínez-Indart L; Imaz-Ayo N; de la Cruz M; de Castro V; López de Munain A; Torrejón Perez I; Gutiérrez-Ibarluzea I
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):197-204. PubMed ID: 30543575
[TBL] [Abstract][Full Text] [Related]
13. Impact of the faecal immunochemical test on colorectal cancer survival.
Gutierrez-Stampa MA; Aguilar V; Sarasqueta C; Cubiella J; Portillo I; Bujanda L
BMC Cancer; 2020 Jul; 20(1):616. PubMed ID: 32611328
[TBL] [Abstract][Full Text] [Related]
14. Screening for colorectal cancer in Italy: 2011-2012 survey.
Zorzi M; Mangone L; Anghinoni E; Baracco S; Borciani E; Caldarella A; Falcini F; Fanetti AC; Ferretti S; Giorgi Rossi P; Michiara M; Randi G; Stracci F; Vicentini M; Zucchetto A; Zappa M;
Epidemiol Prev; 2015; 39(3 Suppl 1):108-14. PubMed ID: 26405782
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
Larsen MB; Njor S; Ingeholm P; Andersen B
Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
[TBL] [Abstract][Full Text] [Related]
16. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy.
Zorzi M; Fedato C; Grazzini G; Stocco FC; Banovich F; Bortoli A; Cazzola L; Montaguti A; Moretto T; Zappa M; Vettorazzi M
Gut; 2011 Jul; 60(7):944-9. PubMed ID: 21193461
[TBL] [Abstract][Full Text] [Related]
17. Screening for colorectal cancer in Italy: 2011-2012 survey.
Zorzi M; Mangone L; Sassatelli R; Baracco S; Budroni M; Castaing M; Cirilli C; Cusimano R; Fusco M; Giacomin A; Giorgi Rossi P; Naldoni C; Pannozzo F; Piffer S; Puppo A; Tisano F; Zappa M;
Epidemiol Prev; 2015; 39(3 Suppl 1):115-25. PubMed ID: 26405783
[TBL] [Abstract][Full Text] [Related]
18. Proportional incidence of interval colorectal cancer in a large population-based faecal immunochemical test screening programme.
Mancini S; Bucchi L; Giuliani O; Ravaioli A; Vattiato R; Baldacchini F; Ferretti S; Sassoli de Bianchi P; Mezzetti F; Triossi O; Serafini M; Ricci E; Palazzi M; Imolesi C; Giovanardi M; Canuti D; Voci C; Altini M; Falcini F
Dig Liver Dis; 2020 Apr; 52(4):452-456. PubMed ID: 32165075
[TBL] [Abstract][Full Text] [Related]
19. Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy.
Giorgi Rossi P; Vicentini M; Sacchettini C; Di Felice E; Caroli S; Ferrari F; Mangone L; Pezzarossi A; Roncaglia F; Campari C; Sassatelli R; Sacchero R; Sereni G; Paterlini L; Zappa M
Am J Gastroenterol; 2015 Sep; 110(9):1359-66. PubMed ID: 26303133
[TBL] [Abstract][Full Text] [Related]
20. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]